The Challenge

When a new drug is introduced to the market, or an existing drug is repurposed for a new disease, pharmaceutical companies must submit an application to health authorities (e.g., the Danish Medicines Council).

  • The application must include research data and a systematic review of scientific studies to prove the drug’s effectiveness.
  • The process typically takes 6-9 months to compile and an additional 4-5 months for regulatory assessment.

The Solution

This AI engine helps pharmaceutical companies prepare an application in less than one week instead of four months.

  • Developing guidelines for drug use in practice can be reduced from four months to one month.
  • This lowers costs and speeds up patient access to new treatments in Denmark and the EU.

EVA is developing an advanced AI engine capable of automatically extracting key information from scientific studies with 95% accuracy, including data on patient groups, treatments, and outcomes. It also correctly assesses research quality in 9 out of 10 articles.